BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Citi maintains buy on Sun Pharmaceutical Industries
Citi maintained its "buy" rating on Sun Pharma with a target price of Rs 975. The company's guidance for FY17 was surprisingly subdued.